Cargando…

Nanozyme-based catalytic theranostics

Nanozymes, a type of nanomaterial with intrinsic enzyme-like activities, have emerged as a promising tool for disease theranostics. As a type of artificial enzyme mimic, nanozymes can overcome the shortcomings of natural enzymes, including high cost, low stability, and difficulty in storage when the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanan, Jin, Yiliang, Cui, Haixia, Yan, Xiyun, Fan, Kelong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048033/
https://www.ncbi.nlm.nih.gov/pubmed/35492517
http://dx.doi.org/10.1039/c9ra09021e
_version_ 1784695853690126336
author Zhang, Yanan
Jin, Yiliang
Cui, Haixia
Yan, Xiyun
Fan, Kelong
author_facet Zhang, Yanan
Jin, Yiliang
Cui, Haixia
Yan, Xiyun
Fan, Kelong
author_sort Zhang, Yanan
collection PubMed
description Nanozymes, a type of nanomaterial with intrinsic enzyme-like activities, have emerged as a promising tool for disease theranostics. As a type of artificial enzyme mimic, nanozymes can overcome the shortcomings of natural enzymes, including high cost, low stability, and difficulty in storage when they are used in disease diagnosis. Moreover, the multi-enzymatic activity of nanozymes can regulate the level of reactive oxygen species (ROS) in various cells. For example, superoxide dismutase (SOD) and catalase (CAT) activity can be used to scavenge ROS, and peroxidase (POD) and oxidase (OXD) activity can be used to generate ROS. In this review, we summarize recent progress on the strategies and applications of nanozyme-based disease theranostics. In addition, we address the opportunities and challenges of nanozyme-based catalytic theranostics in the near future.
format Online
Article
Text
id pubmed-9048033
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90480332022-04-28 Nanozyme-based catalytic theranostics Zhang, Yanan Jin, Yiliang Cui, Haixia Yan, Xiyun Fan, Kelong RSC Adv Chemistry Nanozymes, a type of nanomaterial with intrinsic enzyme-like activities, have emerged as a promising tool for disease theranostics. As a type of artificial enzyme mimic, nanozymes can overcome the shortcomings of natural enzymes, including high cost, low stability, and difficulty in storage when they are used in disease diagnosis. Moreover, the multi-enzymatic activity of nanozymes can regulate the level of reactive oxygen species (ROS) in various cells. For example, superoxide dismutase (SOD) and catalase (CAT) activity can be used to scavenge ROS, and peroxidase (POD) and oxidase (OXD) activity can be used to generate ROS. In this review, we summarize recent progress on the strategies and applications of nanozyme-based disease theranostics. In addition, we address the opportunities and challenges of nanozyme-based catalytic theranostics in the near future. The Royal Society of Chemistry 2019-12-23 /pmc/articles/PMC9048033/ /pubmed/35492517 http://dx.doi.org/10.1039/c9ra09021e Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Zhang, Yanan
Jin, Yiliang
Cui, Haixia
Yan, Xiyun
Fan, Kelong
Nanozyme-based catalytic theranostics
title Nanozyme-based catalytic theranostics
title_full Nanozyme-based catalytic theranostics
title_fullStr Nanozyme-based catalytic theranostics
title_full_unstemmed Nanozyme-based catalytic theranostics
title_short Nanozyme-based catalytic theranostics
title_sort nanozyme-based catalytic theranostics
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048033/
https://www.ncbi.nlm.nih.gov/pubmed/35492517
http://dx.doi.org/10.1039/c9ra09021e
work_keys_str_mv AT zhangyanan nanozymebasedcatalytictheranostics
AT jinyiliang nanozymebasedcatalytictheranostics
AT cuihaixia nanozymebasedcatalytictheranostics
AT yanxiyun nanozymebasedcatalytictheranostics
AT fankelong nanozymebasedcatalytictheranostics